1. Home
  2. VS vs ADXN Comparison

VS vs ADXN Comparison

Compare VS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • ADXN
  • Stock Information
  • Founded
  • VS 2013
  • ADXN 2002
  • Country
  • VS United States
  • ADXN Switzerland
  • Employees
  • VS N/A
  • ADXN N/A
  • Industry
  • VS EDP Services
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VS Technology
  • ADXN Health Care
  • Exchange
  • VS Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • VS 10.1M
  • ADXN 8.1M
  • IPO Year
  • VS N/A
  • ADXN N/A
  • Fundamental
  • Price
  • VS $2.21
  • ADXN $9.00
  • Analyst Decision
  • VS Hold
  • ADXN Strong Buy
  • Analyst Count
  • VS 1
  • ADXN 1
  • Target Price
  • VS $2.00
  • ADXN $30.00
  • AVG Volume (30 Days)
  • VS 58.7K
  • ADXN 7.6K
  • Earning Date
  • VS 08-13-2025
  • ADXN 06-19-2025
  • Dividend Yield
  • VS N/A
  • ADXN N/A
  • EPS Growth
  • VS N/A
  • ADXN N/A
  • EPS
  • VS N/A
  • ADXN 0.10
  • Revenue
  • VS $230,132.00
  • ADXN $278,508.00
  • Revenue This Year
  • VS $3,459.21
  • ADXN $86.57
  • Revenue Next Year
  • VS N/A
  • ADXN N/A
  • P/E Ratio
  • VS N/A
  • ADXN $0.74
  • Revenue Growth
  • VS 64.71
  • ADXN N/A
  • 52 Week Low
  • VS $1.00
  • ADXN $6.51
  • 52 Week High
  • VS $9.59
  • ADXN $13.27
  • Technical
  • Relative Strength Index (RSI)
  • VS 50.63
  • ADXN 55.39
  • Support Level
  • VS $1.92
  • ADXN $8.02
  • Resistance Level
  • VS $2.75
  • ADXN $9.78
  • Average True Range (ATR)
  • VS 0.22
  • ADXN 0.73
  • MACD
  • VS -0.02
  • ADXN 0.02
  • Stochastic Oscillator
  • VS 34.99
  • ADXN 32.94

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: